Premium
Methotrexate vs. fumaric acid esters in moderate‐to‐severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions
Author(s) -
Inzinger M.,
Weger W.,
Heschl B.,
Salmhofer W.,
Quehenberger F.,
Wolf P.
Publication year - 2013
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2012.04596.x
Subject(s) - medicine , psoriasis , methotrexate , plaque psoriasis , clinical endpoint , gastroenterology , wilcoxon signed rank test , complete remission , surgery , chemotherapy , clinical trial , dermatology , mann–whitney u test
To compare the clinical efficacy of methotrexate (MTX) vs. fumaric acid esters (FAE) in psoriasis treated under daily life conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom